Literature DB >> 11027421

Treatment options for the cutaneous manifestations of systemic sclerosis.

J Dutz1.   

Abstract

Systemic Sclerosis is a multisystem disorder with vascular instability as a clinical hallmark. Treatment currently consists of recognition and management of end-organ damage. Dermatologists can assist in the management of these patients by facilitating early diagnosis, and treating cutaneous manifestations such as Raynaud's phenomenon, cutaneous calcinosis, and digital ulceration. New potentially disease-modifying therapies are now undergoing clinical trials.

Entities:  

Mesh：

Year:  2000        PMID： 11027421

Source DB:  PubMed          Journal:  Skin Therapy Lett        ISSN： 1201-5989


  5 in total

1.  Calcinosis cutis at the tarsus of the upper eyelid.

Authors:  Ikhyun Jun; Sung Eun Kim; Sang Yeul Lee; Gi Jeong Kim; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2011-11-22

Review 2.  Scleroderma-like cutaneous syndromes.

Authors:  Yasuji Mori; Veli-Matti Kahari; John Varga
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

3.  Chronic ulcers, calcification and calcified fibrous tumours: phenotypic manifestations of a congenital disorder of heterotopic ossification.

Authors:  Susanne Kupitz; Stuart Enoch; Keith G Harding
Journal:  Int Wound J       Date:  2007-09       Impact factor: 3.315

Review 4.  Dystrophic calcinosis with both a huge calcified mass in the cervical spine and calcification in the chest wall in a patient with rheumatoid overlap syndrome.

Authors:  Tadashi Nakamura; Kei Hirakawa; Hirokazu Takaoka; Ken-Ichi Iyama
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

5.  Dystrophic calcinosis in a patient with overlap syndrome (scleroderma and rheumatoid arthritis) treated by leflunomide: A case report.

Authors:  Sang Yeob Lee; Sung Won Lee; Won Tae Chung
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.